COVID-19 pandemic

R&D

mRNA technologies: Looking beyond COVID vaccines

Following the COVID-19 pandemic, mRNA-based vaccines have been shown to provide rapid and precise immune responses, however, this technology has much wider applications.

R&D

4 years on: Remembering the COVID-19 pandemic

This year, Monday 11th March marked four years since the World Health Organization (WHO) declared COVID-19 a global pandemic.

Market Access

Nine for 2024, Pt 1: From fragility to resilience

This year was a year of significant new beginnings for pharma and healthcare, yet, it was still impacted by the long-term fallouts of the pandemic.

Sales & Marketing

The rise and fall of the pandemic overachievers

Ben Hargreaves examines how Pfizer, BioNTech, and Moderna are preparing for a future without COVID-19 revenue

R&D

Sanofi asks ‘What If?’: Why the ‘big questions’ must be aske...

At the Royal College of Physicians on Thursday 27th July, Sanofi held an event focused on the state of UK life sciences and what can be done at this critical moment in time.

Sales & Marketing